The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
ERK1/2 activation is a therapeutic target in age-related macular degeneration
Open accessAbstract
Deficient expression of the RNase III DICER1, which leads to the accumulation of cytotoxic Alu RNA, has been implicated in degeneration of the retinal pigmented epithelium (RPE) in geographic atrophy (GA), a late stage of age-related macular degeneration that causes blindness in millions of people worldwide. Here we show increased extracellular-signal-regulated kinase (ERK) 1/2 phosphorylation in the RPE of human eyes with GA and that RPE degeneration in mouse eyes and in human cell culture induced by DICER1 depletion or Alu RNA exposure is mediated via ERK1/2 signaling. Alu RNA overexpression or DICER1 knockdown increases ERK1/2 phosphorylation in the RPE in mice and in human cell culture. Alu RNA-induced RPE degeneration in mice is rescued by intravitreous administration of PD98059, an inhibitor of the ERK1/2-activating kinase MEK1, but not by inhibitors of other MAP kinases such as p38 or JNK. These findings reveal a previously unrecognized function of ERK1/2 in the pathogenesis of GA and provide a mechanistic basis for evaluation of ERK1/2 inhibition in treatment of this disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a recent clinical study by the Dridi et al. revealed increased ERK1/2 activity in the RPE of patients suffering from GA as well as in a mouse model of RPE degeneration induced by DICER1 depletion”
From Loss of Extracellular Signal-Regulated Kinase 1/2 in the Retinal Pigment Epithelium Leads to RPE65 Decrease and Retinal Degeneration (2017) · cites this paper as [26]
In the citing paper
“These findings suggest a key role for ERK1/2 in ARMD and support the concept of ERK1/2 inhibition as a possible treatment for this disease”
From Loss of Extracellular Signal-Regulated Kinase 1/2 in the Retinal Pigment Epithelium Leads to RPE65 Decrease and Retinal Degeneration (2017) · cites this paper as [26]
In the citing paper
“by causing toxic levels of RNA from the Alu family of short interspersed elements in the genome and specifically promoting the phosphorylation of ERK1/2 in vivo [ 34 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [34]
In the citing paper
“Another study has shown that PD98059, a potent and selective inhibitor of MEK, inhibits ERK1/2 phosphorylation and blocks RPE degeneration both in RPE cell cultures and in mice [ 34 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [34]
In the citing paper
“Emerging evidence suggests that the MAPK signaling pathway plays a crucial role in the pathogenesis and progression of AMD 34-36 .”
From rAAV-mediated Multi-miRNA Delivery Targeting MAPK Pathway Suppresses Laser-induced Choroidal Neovascularization in Mice (2026) · cites this paper as [35]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
Alu repeats and human genomic diversity
Batzer, M. A., & Deininger, P. L. (2002) · Nature Reviews Genetics · doi:10.1038/nrg798 · Cited by 1,470
LINE-mediated retrotransposition of marked Alu sequences
Dewannieux, M., Esnault, C., & Heidmann, T. (2003) · Nature Genetics · doi:10.1038/ng1223 · Cited by 1,023
Mechanisms of Age-Related Macular Degeneration
Ambati, J., & Fowler, B. J. (2012) · Neuron · doi:10.1016/j.neuron.2012.06.018 · Cited by 1,021
Self-citationAge-related macular degeneration: etiology, pathogenesis, and therapeutic strategies
Ambati, J., Ambati, B. K., Yoo, S. H., Ianchulev, S., & Adamis, A. P. (2003) · Survey of Ophthalmology · doi:10.1016/s0039-6257(03)00030-4 · Cited by 959 · cited 1×
“The clinical and pathological hallmark of GA in human eyes is RPE degeneration (18).”
BackgroundSelf-citationDeininger, P. L., & Batzer, M. A. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1999.2864 · Cited by 909
ERK1/2 MAP kinases in cell survival and apoptosis
Lu, Z., & Xu, S. (2006) · IUBMB Life · doi:10.1080/15216540600957438 · Cited by 648
Keshet, Y., & Seger, R. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-795-2_1 · Cited by 642
DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration
Kaneko, H., Dridi, S., Tarallo, V., Gelfand, B. D., Fowler, B. J., Cho, W. G., Kleinman, M. E., Ponicsan, S. L., Hauswirth, W. W., Chiodo, V. A., et al. (2011) · Nature · doi:10.1038/nature09830 · Cited by 601
Self-citationThe Alu Family of Dispersed Repetitive Sequences
Schmid, C. W., & Jelinek, W. R. (1982) · Science · doi:10.1126/science.6281889 · Cited by 597
Cited by
Risk factors and biomarkers of age-related macular degeneration
Lambert, N. G., ElShelmani, H., Singh, M. K., Mansergh, F. C., Wride, M. A., Padilla, M., Keegan, D., Hogg, R. E., & Ambati, B. K. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.04.003 · Cited by 351
Self-citationcGAS drives noncanonical-inflammasome activation in age-related macular degeneration
Kerur, N., Fukuda, S., Banerjee, D., Kim, Y., Fu, D., Apicella, I., Varshney, A., Yasuma, R., Fowler, B. J., Baghdasaryan, E., et al. (2018) · Nature Medicine · doi:10.1038/nm.4450 · Cited by 286
Self-citationAging is not a disease: Distinguishing age-related macular degeneration from aging
Ardeljan, D., & Chan, C.-C. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.07.003 · Cited by 242
Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity
Fowler, B. J., Gelfand, B. D., Kim, Y., Kerur, N., Tarallo, V., Hirano, Y., Amarnath, S., Fowler, D. H., Radwan, M., Young, M. T., et al. (2014) · Science · doi:10.1126/science.1261754 · Cited by 225
Self-citationStem cell based therapies for age-related macular degeneration: The promises and the challenges
Nazari, H., Zhang, L., Zhu, D., Chader, G. J., Falabella, P., Stefanini, F., Rowland, T., Clegg, D. O., Kashani, A. H., Hinton, D. R., et al. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.06.004 · Cited by 206
Self-citation
Metadata
- Authors
- Dridi, S., Hirano, Y., Tarallo, V., Kim, Y., Fowler, B. J., Ambati, B. K., Bogdanovich, S., Chiodo, V. A., Hauswirth, W. W., Kugel, J. F., Goodrich, J. A., Ponicsan, S. L., Hinton, D. R., Kleinman, M. E., Baffi, J. Z., Gelfand, B. D., & Ambati, J.
- Affiliations
- University of Kentucky (US)
- University of Utah (US)
- University of Florida (US)
- University of Colorado Boulder (US)
- University of Southern California (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-08-06
- Volume
- 109
- Issue
- 34
- Pages
- 13781-13786
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3427082
- OpenAlex
- W2044895376
- Cited by
- 105
- References
- 29
- Citations by year
- 2026: 8 · 2025: 4 · 2024: 4 · 2023: 14 · 2022: 6 · 2021: 9 · 2020: 9 · 2019: 5 · 2018: 5 · 2017: 4 · 2016: 7 · 2015: 12 · 2014: 11 · 2013: 6 · 2012: 1
- FWCI
- 8.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (TL1TR000115, 1ul1rr033173-01, UL1TR000117, UL1TR001998)
- National Heart, Lung, and Blood Institute (T32HL091812)
- National Eye Institute (R01EY020672, P30EY003040, R01EY017950, P30EY021721, R01EY018836, K08EY021521, R01EY001545, R01EY018350, R21EY019778, RC1EY020442, R01EY017182, K08EY021757, R01EY022238, P30EY014800)
- National Institute of General Medical Sciences (R01GM068414)
- National Center for Research Resources (UL1RR-033173, TL1RR033172)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- ERK signaling, age-related macular degeneration, geographic atrophy, retinal pigment epithelium degeneration, DICER1, Alu RNA, RNase III, MEK1 inhibition, PD98059, mitogen-activated protein kinase, therapeutic target
- MeSH terms
- Animals, Enzyme Activation, Enzyme Inhibitors, Flavonoids, Humans, Macular Degeneration, Phosphorylation, Signal Transduction, Gene Expression Regulation, Enzymologic, Mitogen-Activated Protein Kinase 1, Ribonuclease III, Mitogen-Activated Protein Kinase 3, Mice, DEAD-box RNA Helicases, Retinal Pigment Epithelium
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ERK1/2 activation is a therapeutic target in age-related macular degeneration. https://app.cochat.ai/papers/10.1073/pnas.1206494109
- The paper
- Dridi, S., Hirano, Y., Tarallo, V., Kim, Y., Fowler, B. J., Ambati, B. K., Bogdanovich, S., Chiodo, V. A., Hauswirth, W. W., Kugel, J. F., Goodrich, J. A., Ponicsan, S. L., Hinton, D. R., Kleinman, M. E., Baffi, J. Z., Gelfand, B. D., & Ambati, J. (2012). ERK1/2 activation is a therapeutic target in age-related macular degeneration. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1206494109
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.